Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

This open-label, multicenter extension study (NCT02451514) assessed persistence of Neisseria meningitidis serogroups ABCWY antibodies 4 years after primary vaccination. Adolescents and young adults who previously received 2 doses of MenABCWY+OMV (Group III), 1 dose of MenACWY-CRM (Group VI), or newl...

Full description

Bibliographic Details
Main Authors: Xavier Sáez-Llorens, Johnny Beltran-Rodriguez, Jose M. Novoa Pizarro, Ilhem Mensi, Pavitra Keshavan, Daniela Toneatto
Format: Article
Language:English
Published: Taylor & Francis Group 2018-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
antibody persistence
booster dose
menacwy
menabcw
meningococcal vaccine
Online Access:http://dx.doi.org/10.1080/21645515.2018.1457595

Internet

http://dx.doi.org/10.1080/21645515.2018.1457595

Similar Items